US Stock MarketDetailed Quotes
KOD Kodiak Sciences
- 5.900
- +0.110+1.90%
Close Nov 21 16:00 ET
- 5.900
- 0.0000.00%
Post 16:20 ET
310.48MMarket Cap-1620P/E (TTM)
6.030High5.660Low250.70KVolume5.790Open5.790Pre Close1.47MTurnover0.78%Turnover RatioLossP/E (Static)52.62MShares7.77052wk High1.67P/B190.79MFloat Cap2.18552wk Low--Dividend TTM32.34MShs Float171.210Historical High--Div YieldTTM6.39%Amplitude1.370Historical Low5.858Avg Price1Lot Size
About Kodiak Sciences Company
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Company Profile
SymbolKOD
Company NameKodiak Sciences
Listing DateOct 4, 2018
Issue Price10.00
Founded2009
CEODr. Victor Perlroth, M.D.
MarketNASDAQ
Employees111
Fiscal Year Ends12-31
Address1200 Page Mill Road
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94304
Phone1-650-281-0850
Websitehttp://www.kodiak.com
Company Executives
- Name
- Position
- Salary
- Dr. Victor Perlroth, M.D.
- Chief Executive Officer, President and Chairman of the Board
- --
- John A. Borgeson
- Executive Vice President, Chief Financial Officer, Secretary and Principal Accounting Officer
- --
- Robert A. Profusek
- Lead Independent Director
- --
- Charles A. Bancroft
- Independent Director
- --
- Dr. Richard S. Levy,M.D.
- Independent Director
- --
- Dr. Felix J. Baker,PhD
- Independent Director
- --
- Dr. Taiyin Yang, PhD
- Independent Director
- --
- Dr. Bassil I. Dahiyat, PhD.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data